Beasley Allen Calls Upon Merck to Leave Vioxx Off the Market
February 18, 2005 08:20

An FDA advisory panel voted today (17-16) that Vioxx could be placed back on the market. Merck officials have recently stated that they would consider re-introducing the controversial painkiller to the market based on the FDA panel findings. Beasley Allen... (Read this Vioxx Article)

Friday, February 18, 2005 10:09 AM PST matched the following stories: Reuters via Yahoo! News, Thu, 17 Feb 2005 2:21 PM PST FDA Scientist: No Need for Pain Drugs http://news.yahoo.com/news?tmpl=story&u=/nm/20050217/us_nm/health_painkillers_dc_37 A... (Read this Vioxx Article)

Feb. 18, 2005 - Celebrex should remain on the U.S. market despite evidence of its link to heart attacks and strokes in patients who take higher doses, an expert FDA panel said. Experts advising the agency on the future direction of Cox-2 pain drugs, including... (Read this Vioxx Article)

http://my.webmd.com/content/article/101/105996.htm FDA advisory panel members reviewing the safety of the arthritis drug Vioxx and similar drugs accused National Institutes of Health officials of acting irresponsibly when they stopped a study testing the... (Read this Vioxx Article)

Medicis Pharmaceutical Corp. said Friday that regulators approved its emergency treatment for a rare genetic disorder in which the body lacks a key enzyme that breaks down nitrogen in the blood. The Food and Drug Administration approved Medicis' Ammonul... (Read this Vioxx Article)